CAMBRIDGE, MA – Arc Bio announced this week that it has received $1.9 million in funding from the National Institutes of Health (NIH) to support the development of its Research Use Only Galileo ONE metagenomic next generation sequencing workflow for the detection and quantification of microbial species in primary cerebrospinal fluid (CSF) samples. The Phase II Small […]
BAGNEUX, France Regulatory News: Genomic Vision (the “Company” – FR0011799907 – GV) (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced that University of South Florida is implementing the full Molecular Combing workflow using FiberComb, FiberVision S and FiberStudio solutions. Researchers at […]
REDWOOD CITY, Calif. – Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors. Also participating in the round were new investors SoftBank Vision Fund 2, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund and Chimera Abu Dhabi and existing investors Wellington […]
Company expands into key market verticals in diagnostics, therapeutics, and research discovery with solutions for proteins, genomics, and diagnostic assay development services. Waltham, MA – Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced highlights from its first year of operations. Fortis delivered […]
SINGAPORE and MENLO PARK, Calif. — KK Women’s and Children’s Hospital (KKH) and PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration to leverage PacBio technology in understanding the genetic causes of neurodevelopmental disorders. As part of the Bringing Research Innovations for the Diagnosis of GEnetic diseases in Singapore (BRIDGES) program, the collaboration will use HiFi long […]
Winnipeg, MB – Case Western Reserve University (CWRU) has selected Cubresa’s Preclinical NuPET™ Insert System to add to their suite of imaging tools. The NuPET 66 will support research in a wide range of application areas including cancer, neurodegenerative diseases, diabetes, and genetic diseases such as cystic fibrosis, leukodystrophies, and polycystic kidney disease. “The NuPET […]
INDIANAPOLIS – Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on […]
WALTHAM, Mass. — Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. and Europe. The Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution combining the GMP […]
SAN JOSE, Calif. — Takara Bio USA, Inc. (TBUSA) today announced that the European Patent Office has reviewed and confirmed the validity of TBUSA’s granted European patent EP 3105325, entitled “Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same.” TBUSA’s patent was opposed […]
Element Strengthens Leadership Team to Advance Novel Applications Development and Scientific Affairs
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointment of Shawn Levy, Ph.D., as Senior Vice President of Applications and Scientific Affairs. A world-renowned pioneer in genomics research, Dr. Levy brings more than 20 years of in-depth knowledge to support Element’s growth and strategic plans for its first sequencing platform, AVITI™, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
